Ganesh A Thakur Selected Research

Cautery

1/2020

Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ganesh A Thakur Research Topics

Disease

16	Pain (Aches) 01/2020 - 12/2002
11	Hyperalgesia 01/2022 - 11/2008
9	Neuralgia (Stump Neuralgia) 01/2022 - 11/2008
7	Inflammation (Inflammations) 06/2020 - 11/2008
5	Hypersensitivity (Allergy) 01/2020 - 11/2008
5	Hypothermia 01/2019 - 06/2011
4	Peripheral Nervous System Diseases (PNS Diseases) 12/2020 - 11/2008
3	Glaucoma 11/2021 - 07/2005
3	Chronic Pain 01/2020 - 04/2015
3	Nausea 03/2013 - 03/2008
2	Absence Epilepsy (Childhood Absence Epilepsy) 06/2022 - 01/2021
2	Seizures (Absence Seizure) 01/2022 - 01/2021
2	Multiple Sclerosis 04/2021 - 07/2005
2	Schizophrenia (Dementia Praecox) 04/2021 - 01/2021
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2018
2	Abdominal Pain (Pain, Abdominal) 11/2019 - 10/2018
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2019 - 10/2018
2	Neoplasms (Cancer) 10/2019 - 03/2019
2	Ataxia (Dyssynergia) 01/2017 - 06/2011
2	Vomiting 03/2013 - 03/2008
1	Sciatic Neuropathy (Lesion of Sciatic Nerve) 01/2022
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2021
1	Neuroinflammatory Diseases 04/2021
1	Hyperoxia 01/2021
1	COVID-19 01/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Epilepsy (Aura) 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	Corneal Injuries 01/2020
1	Tremor (Tremors) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019
1	Carcinoma (Carcinomatosis) 03/2019
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Huntington Disease (Huntington's Disease) 01/2019

Drug/Important Bio-Agent (IBA)

18	CannabinoidsIBA 01/2022 - 03/2008
10	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2022 - 03/2013
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 11/2008
7	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2021 - 04/2015
6	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022 - 06/2011
6	3- (2- nitro- 1- phenylethyl)- 2- phenyl- 1H- indoleIBA 01/2022 - 11/2018
6	Formaldehyde (Formol)FDA Link 11/2018 - 04/2015
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 12/2002
4	EndocannabinoidsIBA 01/2022 - 03/2012
4	4- (4- bromophenyl)- 3a,4,5,9b- tetrahydro- 3H- cyclopenta(c)quinoline- 8- sulfonamideIBA 04/2021 - 01/2016
4	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2017
4	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2020 - 07/2005
4	Pharmaceutical PreparationsIBA 10/2017 - 03/2008
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2021 - 10/2015
3	Dizocilpine Maleate (Dizocilpine)IBA 01/2021 - 10/2015
3	CytokinesIBA 12/2020 - 03/2012
3	Freund's AdjuvantIBA 11/2018 - 10/2015
3	2- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenolIBA 01/2017 - 10/2015
3	9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA 08/2013 - 01/2013
3	RimonabantIBA 03/2013 - 03/2008
3	AM4113IBA 02/2013 - 03/2008
2	AM 1241IBA 01/2022 - 03/2012
2	Nicotine FDA Link 01/2021 - 10/2019
2	Interleukin-10 (Interleukin 10)IBA 12/2020 - 03/2012
2	LigandsIBA 01/2020 - 01/2014
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 02/2013
2	Opioid Analgesics (Opioids)IBA 01/2020 - 02/2013
2	Serotonin (5 Hydroxytryptamine)IBA 11/2019 - 10/2018
2	AM9405IBA 11/2019 - 10/2018
2	Antineoplastic Agents (Antineoplastics)IBA 10/2019 - 11/2008
2	1,4- diazabicyclo(3.2.2)nonan- 4- yl(5- (3- (trifluoromethyl)phenyl)furan- 2- yl)methanoneIBA 01/2018 - 04/2015
2	Mesylates (Mesylate)IBA 02/2013 - 01/2013
1	TRPV1 receptorIBA 01/2022
1	ElementsIBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	ABX-1431IBA 01/2022
1	CationsIBA 01/2022
1	2-phenylindoleIBA 11/2021
1	Cholinergic Agents (Cholinergics)IBA 04/2021
1	Antipsychotic Agents (Antipsychotics)IBA 04/2021
1	Actins (F Actin)IBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Superoxide Dismutase-1IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	CannabidiolIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Sucrose (Saccharose)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 12/2020
1	Ligand-Gated Ion ChannelsIBA 06/2020
1	Capsaicin (Zostrix)FDA Link 01/2020
1	Transient Receptor Potential ChannelsIBA 01/2020
1	Naloxone (Narcan)FDA LinkGeneric 01/2020
1	Small Interfering RNA (siRNA)IBA 03/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2019
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2019

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 09/2012
4	Therapeutics 01/2021 - 10/2019
3	Analgesia 08/2013 - 01/2013
1	Induced Hyperthermia (Thermotherapy) 01/2022
1	Self Administration (Administration, Self) 01/2021
1	Cautery 01/2020